Abstract
The objective was to compare the expression of plasma stromal cell-derived factor 1 and the gene polymorphism in patients with pelvic inflammatory disease and healthy controls. The enzyme-linked immunosorbent assay and polymerase chain reaction—restriction fragment length polymorphism were, respectively, used to measure the plasma stromal cell-derived factor 1a level and stromal cell-derived factor 1 polymorphism in 50 healthy controls and in 44 patients with pelvic inflammatory disease before and after they received routine treatment protocols. The level of plasma stromal cell-derived factor 1a was elevated in patients with pelvic inflammatory disease compared to normal controls and decreased significantly after treatment. There were significant correlations between plasma stromal cell-derived factor 1 a level and neutrophil count as well as between stromal cell-derived factor 1 a level and white blood cell count in patients with pelvic inflammatory disease. There was no significantly different distribution of stromal cell-derived factor 1 genotypes between patients with pelvic inflammatory disease and normal controls. Patients with pelvic inflammatory disease having stromal cell-derived factor 1–3’ A allele were associated with significantly elevated plasma stromal cell-derived factor 1 a concentration compared to patients with pelvic inflammatory disease having G/G homozygous alleles (P < .02). In normal controls, there was no significant difference in the plasma stromal cell-derived factor 1 level between individuals with and without stromal cell-derived factor 1–3’A allele. When the cutoff level of plasma stromal cell-derived factor 1a level was determined to be 2192 pg/mL based on receiver-operating characteristic curve, the sensitivity, specificity, positive predictive value, and negative predictive value as well as accuracy were 77.3%, 88.0%, 85.0%, 81.5%, and 83.0%. In conclusion, when the cutoff level was determined to be 2192 pg/mL, plasma stromal cell-derived factor 1 a level can be used to predict pelvic inflammatory disease.
Similar content being viewed by others
References
Borish LC, Steinke JW. Cytokines and chemokines. J Allergy Clin Immunol. 2003;111:S460–S475.
Crazzolara R, Kreczy A, Mann G, et al. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia. Br J Haematol. 2001;115:545–553.
Shimoda K, Begum NA, Shibuta K, et al. Interleukin–8 and hIRH (SDF1-alpha/PBSF) mRNA expression and histologi-cal activity index in patients with chronic hepatitis C. Hepatol-ogy. 1998;28:108–115.
Buckley CD, Amft N, Bradfield PF, et al. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol. 2000;165:3423–3429.
Sutton A, Friand V, Brule-Donneger S, et al. Stromal cell-derived factor 1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion. Mol Cancer Res. 2007;5:21–33.
Gorter DJ, Reijmers RM, Beuling EA, et al. The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells. Blood. 2008;111:3364–3372.
Kerfoot SM, Andonegui G, Bonder CS, Liu L. Exogenous stromal cell-derived factor–1 induces modest leukocyte recruitment in vivo. Am J Physiol Heart Circ Physiol. 2008;294:H2524–H2534.
Abi-Younes S, Sauty A, Mach F, Sukhova GK, Libby P, Luster AD. The stromal cell-derived factor–1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res. 2000;86:131–138.
Burgoyne CH, Field SL, Brown AK, et al. Abnormal T-cell differentiation persists in rheumatoid arthritis patients in clinical remission and predicts relapse. Ann Rheum Dis. 2008;67:750–757.
Leone AM, Rutella S, Bonanno G, et al. Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int J Cardiol. 2006;111:202–208.
Shirozu M, Nakano T, Inazawa J, et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics. 1995;28:495–500.
Apostolakis S, Baritaki S, Kochiadakis GE, Igoumenidis NE, Panutsopulos D, Spandidos DA. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease. Thromb Res. 2007;119:63–71.
Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science. 1998;279:389–393.
Soriano A, Martinez C, Garcia F, et al. Plasma stromal cell-derived factor (SDF)–1 levels, SDF1–3’A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis. 2002;186:922–931.
Brambilla A, Villa C, Rizzardi G, et al. Shorter survival of SDF1–3’A/3’A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection. J Infect Dis. 2000;182:311–315.
Oliveira CE, Cavassin GG, Perim Ade L, et al. Stromal cell-derived factor–1 chemokine gene variant in blood donors and chronic myelogenous leukemia patients. J Clin Lab Anal. 2007;21:49–54.
Coll B, Parra S, Alonso-Villaverde C, et al. The role of immunity and inflammation in the progression of atherosclerosis in patients with HIV infection. Stroke. 2007;38:2477–2484.
Corbeil LB, Shively JN, Duncan JR, Schurig GG, Winter AJ. Bovine venereal vibriosis. Ultrastructure of endometrial inflammatory lesions. Lab Invest. 1975;33:187–192.
Tsai HT, Wang PH, Tee YT, Lin LY, Hsieh YS, Yang SF. Imbalanced serum concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease. Fertil Steril. IN PRESS.
Dayan L. Pelvic inflammatory disease. Aust Fam Physician. 2006;35:858–862.
Gray-Swain MR, Peipert JF. Pelvic inflammatory disease in adolescents. Curr Opin Obstet Gynecol. 2006;18:503–510.
Hadgu A, Westrom L, Brooks CA, Reynolds GH, Thompson SE. Predicting acute pelvic inflammatory disease: a multivariate analysis. Am J Obstet Gynecol. 1986;155:954–960.
Angerman NS, Evans MI, Moravec WD, Schumacher GF, Hajj SN. C-reactive protein in the evaluation of antibiotic therapy for pelvic infection. J Reprod Med. 1980;25:63–66.
Katsuta T, Lim C, Shimoda K, et al. Interleukin–8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease. Am J Gastroenterol. 2000;95:3157–3164.
Kinnunen A, Molander P, Morrison R, et al. Chlamydial heat shock protein 60—specific T cells in inflamed salpingeal tissue. Fertil Steril. 2002;77:162–166.
Sukhikh GT, Kasabulatov NM, Van’ko LV, Ordzhonikidze NV, Veryasov VN, Danelyan SZh. Ratio between the number of Th1 and Th2 lymphocytes in the peripheral blood and concentration of proinflammatory cytokines in lochia of women with postpartum endometritis. Bull Exp Biol Med. 2005;140:672–674.
Chen KS, Wang PH, Yang SF, et al. Significant elevation of a Th2 cytokine, interleukin–10, in pelvic inflammatory disease. Clin Chem Lab Med. 2008;46:1609–1616.
Lee SA, Tsai HT, Ou HC, et al. Plasma interleukin–1beta, –6, –8 and tumor necrosis factor-alpha as highly informative markers of pelvic inflammatory disease. Clin Chem Lab Med. 2008;46:997–1003.
Kimura R, Nishioka T, Ishida T. The SDF1-G801A polymorphism is not associated with SDF1 gene expression in Epstein-Barr virus-transformed lymphoblastoid cells. Genes Immun. 2003;4:356–61.
Sei S, O’Neill DP, Stewart SK, et al. Increased level of stromal cell-derived factor–1 mRNA in peripheral blood mononuc-lear cells from children with AIDS-related lymphoma. Cancer Res. 2001;61:5028–5037.
Author information
Authors and Affiliations
Corresponding author
Additional information
No potential conflicts of interest were disclosed.
Rights and permissions
About this article
Cite this article
Tsai, HT., Tee, YT., Hsieh, YH. et al. Elevated Plasma Stromal Cell-derived Factor 1 Protein and its Gene Polymorphism in Patients With Pelvic Inflammatory Disease. Reprod. Sci. 16, 610–617 (2009). https://doi.org/10.1177/1933719109332829
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719109332829